Chelation: Harnessing and enhancing heavy metal detoxification - A review

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Sears, Margaret E ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; CADMIUM; CHELATING AGENT; CILANTRO EXTRACT; DIMERCAPROL; EDETIC ACID; GLUTATHIONE; HEAVY METAL; LEAD; MERCURY; METALLOTHIONEIN; PENICILLAMINE; PLANT EXTRACT; SUCCIMER; THIOCTIC ACID; UNCLASSIFIED DRUG; UNITHIOL;

AUTISM; BLOOD BRAIN BARRIER; CARDIOVASCULAR DISEASE; CHELATION THERAPY; CORIANDER; DETOXIFICATION; HEAVY METAL POISONING; HEAVY METAL REMOVAL; HUMAN; METAL BINDING; METAL METABOLISM; NONHUMAN; REVIEW; TOXICOKINETICS; ANIMAL; CHEMISTRY; INTOXICATION; METABOLISM; METHODOLOGY;

ANIMALS; CHELATING AGENTS; CHELATION THERAPY; HUMANS; METALS, HEAVY; POISONING;

EID: 84878344952     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/219840     Document Type: Review

References (122)

1. Apostoli P., Cornelis R., Duffus J., Elemental speciation in human health risk assessment. United Nations Environment Programme, the International Labour Organization and the World Health Organization, 2006, http://apps.who.int/iris/ bitstream/10665/43442/1/9241572345-eng.pdf
2. Matović V., Buha A., Bulat Z., Dukić-Ćosić D., Cadmium toxicity revisited: focus on oxidative stress induction and interactions with zinc and magnesium. Archives of Industrial Hygiene and Toxicology 2011 62 65 76
3. Fowler B. A., Monitoring of human populations for early markers of cadmium toxicity: a review. Toxicology and Applied Pharmacology 2009 238 3 294 300 10.1016/j.taap.2009.05.004
4. Ciesielski T., Weuve J., Bellinger D. C., Cadmium exposure and neurodevelopmental outcomes in U.S. children. Environmental Health Perspectives 2012 120 758 763 10.1289/ehp.1104152
5. Agency for Toxic Substances and Disease Registry, Toxicological Profile: Cadmium. 2008, http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=48&tid=15
6. Flora G., Gupta D., Tiwari A., Toxicity of lead: a review with recent updates. Interdisciplinary Toxicology 2012 5 47 58 10.2478/v10102-012-0009-2
7. National Toxicology Program, Health Effects of Low-level Lead Evaluation. 2012, http://ntp.niehs.nih.gov/?objectid=4F04B8EA-B187-9EF2-9F9413C68E76458E
8. Agency for Toxic Substances and Disease Registry, Toxicological Profile: Lead. 2007, http://www.atsdr.cdc.gov/ToxProfiles/tp.asp?id=96&tid=22
9. Sakamoto M., Murata K., Kakita A., Sasaki M., Liu G., Cai Y., O'Driscoll N., A review of mercury toxicity with special reference to methylmercury. Environmental Chemistry and Toxicology of Mercury 2011 New York, NY, USA John Wiley & Sons 501 516
10. Bernhoft R. A., Mercury toxicity and treatment: a review of the literature. Journal of Environmental and Public Health 2012 2012 10 460508 10.1155/2012/460508
11. Committee on the Toxicological Effects of Methylmercury, Board on Environmental Studies and Toxicology, National Research Council, Toxicological Effects of Methylmercury 2000 Washington, DC, USA The National Academies Press
12. Agency for Toxic Substances and Disease Registry, Toxicological Profile: Mercury 1999 Atlanta, Ga, USA US Department of Health and Human Services. Public Health Service. http://www.atsdr.cdc.gov/ToxProfiles/TP.asp?id=115&tid=24
13. World Health Organization, Global Status Report on Noncommunicable Diseases 2010. http://www.who.int/nmh/publications/ncd-report2010/en/
14. International Agency for Research on Cancer (IARC), Agents Classified by the IARC Monographs 2012 1-106. http://monographs.iarc.fr/ENG/Classification/ ClassificationsAlphaOrder.pdf
15. Lanphear B. P., Hornung R., Khoury J., Yolton K., Baghurst P., Bellinger D. C., Canfield R. L., Dietrich K. N., Bornschein R., Greene T., Rothenberg S. J., Needleman H. L., Schnaas L., Wasserman G., Graziano J., Roberts R., Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environmental Health Perspectives 2005 113 7 894 899 2-s2.0-22144464444 10.1289/ehp.7688 (Pubitemid 40984191)
16. National Center for Environmental Health, New Blood Lead Level Information 2012. http://www.cdc.gov/nceh/lead/ACCLPP/blood-lead-levels.htm
17. US Environmental Protection Agency, Fish Consumption Advisories 2012. http://water.epa.gov/scitech/swguidance/fishshellfish/fishadvisories/index.cfm
18. Government of Canada; Aboriginal Affairs and Northern Development Canada, Metals of Concern Fact Sheet Series: Cadmium 2011. http://www.aadnc-aandc.gc. ca/eng/1316038300971/1316038365744
19. Sears M. E., Genuis S. J., Environmental determinants of chronic disease and medical approaches: recognition, avoidance, supportive therapy, and detoxification. Journal of Environmental and Public Health 2012 2012 15 356798 10.1155/2012/356798
20. Flora S. J. S., Metal poisoning: threat and management. Al Ameen Journal of Medical Science 2009 2 4 26
21. Sears M. E., Kerr K. J., Bray R. I., Arsenic, cadmium, lead, and mercury in sweat: a systematic review. Journal of Environmental and Public Health 2012 2012 10 184745 10.1155/2012/184745
22. Rooney J. P. K., The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury. Toxicology 2007 234 3 145 156 10.1016/j.tox.2007.02.016 (Pubitemid 46635957)
23. Thevenod F., Catch me if you can! Novel aspects of cadmium transport in mammalian cells. BioMetals 2010 23 857 875 10.1007/s10534-010-9309-1
24. Bridges C. C., Joshee L., Zalups R. K., Multidrug resistance proteins and the renal elimination of inorganic mercury mediated by 2,3-dimercaptopropane-1- sulfonic acid and meso-2,3-dimercaptosuccinic acid. Journal of Pharmacology and Experimental Therapeutics 2008 324 1 383 390 2-s2.0-37349054265 10.1124/jpet.107.130708 (Pubitemid 350294186)
25. Bridges C. C., Joshee L., Zalups R. K., MRP2 and the DMPS- and DMSA-mediated elimination of mercury in TR- and control rats exposed to thiol S-conjugates of inorganic mercury. Toxicological Sciences 2008 105 1 211 220 2-s2.0-49249100746 10.1093/toxsci/kfn107
26. Oh S.-H., Lee S.-Y., Choi C.-H., Lee S.-H., Lim S.-C., Cadmium adaptation is regulated by multidrug resistance-associated protein-mediated Akt pathway and metallothionein induction. Archives of Pharmacal Research 2009 32 6 883 891 10.1007/s12272-009-1610-6
27. Lynes M. A., Kang Y. J., Sensi S. L., Perdrizet G. A., Hightower L. E., Heavy metal ions in normal physiology, toxic stress, and cytoprotection. Annals of the New York Academy of Sciences 2007 1113 159 172 2-s2.0-35548944034 10.1196/annals.1391.010 (Pubitemid 350015009)
28. Klaassen C. D., Liu J., Diwan B. A., Metallothionein protection of cadmium toxicity. Toxicology and Applied Pharmacology 2009 238 3 215 220 10.1016/j.taap.2009.03.026
29. Wang G., Fowler B. A., Roles of biomarkers in evaluating interactions among mixtures of lead, cadmium and arsenic. Toxicology and Applied Pharmacology 2008 233 1 92 99 10.1016/j.taap.2008.01.017
30. Franco R., Sánchez-Olea R., Reyes-Reyes E. M., Panayiotidis M. I., Environmental toxicity, oxidative stress and apoptosis: Ménage à Trois. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2009 674 3 22 10.1016/j.mrgentox.2008.11.012
31. Geier D. A., Kern J. K., Garver C. R., Biomarkers of environmental toxicity and susceptibility in autism. Journal of the Neurological Sciences 2009 280 1 101 108 10.1016/j.jns.2008.08.021
32. Pal R., Rai J. P. N., Phytochelatins: peptides involved in heavy metal detoxification. Applied Biochemistry and Biotechnology 2010 160 3 945 963 10.1007/s12010-009-8565-4
33. Asagba S. O., Role of diet in absorption and toxicity of oral cadmium-a review of literature. African Journal of Biotechnology 2009 8 25 10.4314/ajb.v8i25
34. Ou S., Gao K., Li Y., An in vitro study of wheat bran binding capacity for Hg, Cd, and Pb. Journal of Agricultural and Food Chemistry 1999 47 11 4714 4717 10.1021/jf9811267
35. Callegaro M., Milbradt B. G., Diettrich T., Influence of cereal bran supplement on cadmium effects in growing rats. Human & Experimental Toxicology 2010 29 6 467 476 10.1177/0960327109357777
36. Berglund M., Akesson A., Nermell B., Vahter M., Intestinal absorption of dietary cadmium in women depends on body iron stores and fiber intake. Environmental Health Perspectives 1994 102 12 1058 1066 2-s2.0-0028580065
37. Rowland I. R., Mallett A. K., Flynn J., Hargreaves R. J., The effect of various dietary fibres on tissue concentration of chemical form of mercury after methylmercury exposure in mice. Archives of Toxicology 1986 59 2 94 98 2-s2.0-0022483326 (Pubitemid 16068333)
38. Callegaro M. G. K., Milbradt B. G., Alves E., Effect of wheat bran and flaxseed on cadmium effects and retention in rats. Human & Experimental Toxicology 2011 30 981 991 10.1177/0960327110384526
39. Eliaz I., Weil E., Wilk B., Integrative medicine and the role of modified citrus pectin/alginates in heavy metal chelation and detoxification-five case reports. Forschende Komplementarmedizin 2007 14 6 358 364 2-s2.0-38749105814 10.1159/000109829 (Pubitemid 351185629)
40. Uchikawa T., Kumamoto Y., Maruyama I., Kumamoto S., Ando Y., Yasutake A., The enhanced elimination of tissue methylmercury in Parachlorella beijerinckii-fed mice. Journal of Toxicological Sciences 2011 36 1 121 126 2-s2.0-79551609855 10.2131/jts.36.121
41. Siao F. Y., Lu J. F., Wang J. S., Inbaraj B. S., Chen B. H., In vitro binding of heavy metals by an edible biopolymer poly(γ -glutamic acid). Journal of Agricultural and Food Chemistry 2009 57 2 777 784 10.1021/jf803006r
42. Abdalla F. H., Bellé L. P., de Bona K. S., Bitencourt P. E. R., Pigatto A. S., Moretto M. B., Allium sativum L. extract prevents methyl mercury-induced cytotoxicity in peripheral blood leukocytes (LS). Food and Chemical Toxicology 2010 48 1 417 421 2-s2.0-72149123385 10.1016/j.fct.2009.10. 033
43. Lampe J. W., Peterson S., Brassica, biotransformation and cancer risk: genetic polymorphisms alter the preventive effects of cruciferous vegetables. Journal of Nutrition 2002 132 10 2991 2994 2-s2.0-0036792160
44. Suru S. M., Onion and garlic extracts lessen cadmium-induced nephrotoxicity in rats. BioMetals 2008 21 6 623 633 2-s2.0-55149092318 10.1007/s10534-008-9148-5
45. Senapati S. K., Dey S., Dwivedi S. K., Swarup D., Effect of garlic (Allium sativum L.) extract on tissue lead level in rats. Journal of Ethnopharmacology 2001 76 3 229 232 2-s2.0-0034937249 10.1016/S0378-8741(01) 00237-9 (Pubitemid 32633848)
46. Abascal K., Yarnell E., Cilantro-culinary herb or miracle medicinal plant? Alternative and Complementary Therapies 2012 18 259 264 10.1089/act.2012.18507
47. Aga M., Iwaki K., Ueda Y., Ushio S., Masaki N., Fukuda S., Kimoto T., Ikeda M., Kurimoto M., Preventive effect of Coriandrum sativum (Chinese parsley) on localized lead deposition in ICR mice. Journal of Ethnopharmacology 2001 77 2-3 203 208 2-s2.0-0034861684 10.1016/S0378-8741(01)00299-9 (Pubitemid 32782629)
48. Deldar K., Nazemi E., Balali Mood M., Effect of Coriandrum sativum L. extract on lead excretion in 3-7 year old children. Journal of Birjand University of Medical Sciences 2008 15 11 19
49. Gürer H., Ozgünes H., Saygin E., Ercal N., Antioxidant effect of taurine against lead-induced oxidative stress. Archives of Environmental Contamination and Toxicology 2001 41 4 397 402 10.1007/s002440010265 (Pubitemid 33020158)
50. Hwang D. F., Wang L. C., Effect of taurine on toxicity of cadmium in rats. Toxicology 2001 167 3 173 180 10.1016/S0300-483X(01)00472-3 (Pubitemid 32900626)
51. Flora S. J. S., Pande M., Bhadauria S., Kannan G. M., Combined administration of taurine and meso 2,3-dimercaptosuccinic acid in the treatment of chronic lead intoxication in rats. Human and Experimental Toxicology 2004 23 4 157 166 2-s2.0-2342605551 10.1191/0960327104ht432oa (Pubitemid 38607485)
52. Caylak E., Aytekin M., Halifeoglu I., Antioxidant effects of methionine, α -lipoic acid, N-acetylcysteine and homocysteine on lead-induced oxidative stress to erythrocytes in rats. Experimental and Toxicologic Pathology 2008 60 4-5 289 294 2-s2.0-46649091905 10.1016/j.etp.2007.11.004
53. Pande M., Flora S. J. S., Lead induced oxidative damage and its response to combined administration of α -lipoic acid and succimers in rats. Toxicology 2002 177 2-3 187 196 2-s2.0-0037102716 10.1016/S0300-483X(02)00223-8 (Pubitemid 34804306)
54. Flora S. J. S., Arsenic-induced oxidative stress and its reversibility following combined administration of N-acetylcysteine and meso 2,3-dimercaptosuccinic acid in rats. Clinical and Experimental Pharmacology and Physiology 1999 26 11 865 869 2-s2.0-0032693563 10.1046/j.1440-1681.1999.03157.x (Pubitemid 29513624)
55. Kannan G. M., Flora S. J. S., Combined administration of N-acetylcysteine and monoisoamyl DMSA on tissue oxidative stress during arsenic chelation therapy. Biological Trace Element Research 2006 110 1 43 59 2-s2.0-33646865247 10.1385/BTER:110:1:43 (Pubitemid 43780415)
56. Blanuša M., Varnai V. M., Piasek M., Kostial K., Chelators as antidotes of metal toxicity: therapeutic and experimental aspects. Current Medicinal Chemistry 2005 12 23 2771 2794 2-s2.0-27744527460 10.2174/ 092986705774462987 (Pubitemid 41601574)
57. Cacciatore I., Baldassarre L., Fornasari E., Mollica A., Pinnen F., Recent advances in the treatment of neurodegenerative diseases based on GSH delivery systems. Oxidative Medicine and Cellular Longevity 2012 2012 12 10.1155/2012/240146 240146
58. Becker A., Soliman K., The role of intracellular glutathione in inorganic mercury-induced toxicity in neuroblastoma cells. Neurochemical Research 2009 34 9 1677 1684 10.1007/s11064-009-9962-3
59. Kaur P., Aschner M., Syversen T., Glutathione modulation influences methyl mercury induced neurotoxicity in primary cell cultures of neurons and astrocytes. NeuroToxicology 2006 27 4 492 500 2-s2.0-33744990187 10.1016/j.neuro.2006.01.010 (Pubitemid 43867781)
60. Rosenblat M., Volkova N., Coleman R., Aviram M., Anti-oxidant and anti-atherogenic properties of liposomal glutathione: studies in vitro, and in the atherosclerotic apolipoprotein E-deficient mice. Atherosclerosis 2007 195 2 e61 e68 2-s2.0-36049009458 10.1016/j.atherosclerosis.2007.05.012 (Pubitemid 350087977)
61. Zeevalk G. D., Bernard L. P., Guilford F. T., Liposomal-glutathione provides maintenance of intracellular glutathione and neuroprotection in mesencephalic neuronal cells. Neurochemical Research 2010 35 10 1575 1587 2-s2.0-77957582975 10.1007/s11064-010-0217-0
62. Brandão R., Borges L. P., Nogueira C. W., Concomitant administration of sodium 2,3-dimercapto-1-propanesulphonate (DMPS) and diphenyl diselenide reduces effectiveness of DMPS in restoring damage induced by mercuric chloride in mice. Food and Chemical Toxicology 2009 47 8 1771 1778 2-s2.0-68649126272 10.1016/j.fct.2009.04.035
63. Li Y.-F., Dong Z., Chen C., Organic selenium supplementation increases mercury excretion and decreases oxidative damage in long-term mercury-exposed residents from Wanshan, China. Environmental Science & Technology 2012 46 11313 11318 10.1021/es302241v
64. Peraza M. A., Ayala-Fierro F., Barber D. S., Casarez E., Rael L. T., Effects of micronutrients on metal toxicity. Environmental Health Perspectives 1998 106 1 203 216 2-s2.0-0031954951 (Pubitemid 28196045)
65. Flora S. J. S., Bhadauria S., Kannan G. M., Singh N., Arsenic induced oxidative stress and the role of antioxidant supplementation during chelation: a review. Journal of Environmental Biology 2007 28 2 333 347 2-s2.0-34247576377 (Pubitemid 46683614)
66. Ito Y., Niiya Y., Otani M., Sarai S., Shima S., Effect of food intake on blood lead concentration in workers occupationally exposed to lead. Toxicology Letters 1987 37 2 105 114 10.1016/0378-4274(87)90145-7 (Pubitemid 17097327)
67. Aremu D. A., Madejczyk M. S., Ballatori N., N-acetylcysteine as a potential antidote and biomonitoring agent of methylmercury exposure. Environmental Health Perspectives 2008 116 1 26 31 2-s2.0-40949106884
68. Joshi D., Mittal D., Shrivastav S., Shukla S., Srivastav A. K., Combined effect of N-acetyl cysteine, zinc, and selenium against chronic dimethylmercury-induced oxidative stress: a biochemical and histopathological approach. Archives of Environmental Contamination and Toxicology 2011 61 4 558 567 10.1007/s00244-011-9656-0
69. van Barneveld A. A., van den Hamer C. J. A., Influence of Ca and Mg on the uptake and deposition of Pb and Cd in mice. Toxicology and Applied Pharmacology 1985 79 1 1 10 10.1016/0041-008X(85)90363-1 (Pubitemid 15015777)
70. Ettinger A. S., Lamadrid-Figueroa H., Téllez-Rojo M. M., Mercado-García A., Peterson K. E., Schwartz J., Hu H., Hernández-Avila M., Effect of calcium supplementation on blood lead levels in pregnancy: a randomized placebo-controlled trial. Environmental Health Perspectives 2009 117 1 26 31 2-s2.0-60749096841 10.1289/ehp.11868
71. Ettinger A. S., Téllez-Rojo M. M., Amarasiriwardena C., Peterson K. E., Schwartz J., Aro A., Hu H., Hernández-Avila M., Influence of maternal bone lead burden and calcium intake on levels of lead in breast milk over the course of lactation. American Journal of Epidemiology 2006 163 1 48 56 2-s2.0-29344459843 10.1093/aje/kwj010 (Pubitemid 43007114)
72. Ettinger A. S., Hu H., Hernandez-Avila M., Dietary calcium supplementation to lower blood lead levels in pregnancy and lactation. Journal of Nutritional Biochemistry 2007 18 3 172 178 2-s2.0-33846827104 10.1016/j.jnutbio.2006.12.007 (Pubitemid 46216811)
73. Zimmermann M. B., Muthayya S., Moretti D., Kurpad A., Hurrell R. F., Iron fortification reduces blood lead levels in children in Bangalore, India. Pediatrics 2006 117 6 2014 2021 2-s2.0-33745310791 10.1542/peds.2005-2440 (Pubitemid 46071246)
74. Lanphear B. P., The conquest of lead poisoning: a pyrrhic victory. Environmental Health Perspectives 2007 115 10 A484 A485 2-s2.0-35448965206 10.1289/ehp.10871 (Pubitemid 47618071)
75. Vishwanath P., Prashant A., Devanand D., Nayak N., D'Souza V., Venkatesh T., Screening of school children for blood lead levels and attempts to reduce them by nonpharmacological means in a coastal city of India. Indian Journal of Medical Sciences 2008 62 5 185 192 2-s2.0-44949137204 (Pubitemid 351821549)
76. Rosado J. L., López P., Kordas K., García-Vargas G., Ronquillo D., Alatorre J., Stoltzfus R. J., Iron and/or zinc supplementation did not reduce blood lead concentrations in children in a randomized, placebo-controlled trial. Journal of Nutrition 2006 136 9 2378 2383 2-s2.0-33748333327 (Pubitemid 44329999)
77. Aposhian H. V., DMSA and DMPS-water soluble antidotes for heavy metal poisoning. Annual Review of Pharmacology and Toxicology 1983 23 193 215 10.1146/annurev.pa.23.040183.001205 (Pubitemid 13079373)
78. Asledu P., Moulton T., Blum C. B., Roldan E., Lolacono N. J., Graziano J. H., Metabolism of meso-2,3-dimercaptosuccinic acid in lead-poisoned children and normal adults. Environmental Health Perspectives 1995 103 7-8 734 739 2-s2.0-0029114911
79. Bradberry S., Vale A., Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning. Clinical Toxicology 2009 47 7 617 631 2-s2.0-69149087793 10.1080/15563650903174828
80. Bradberry S., Vale A., A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning Sodium calcium edetate and DMSA in lead poisoning. Clinical Toxicology 2009 47 9 841 858 2-s2.0-70350458849 10.3109/15563650903321064
81. Hurlbut K. M., Maiorino R. M., Mayersohn M., Dart R. C., Bruce D. C., Aposhian H. V., Determination and metabolism of dithiol chelating agents XVI: pharmacokinetics of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteers. Journal of Pharmacology and Experimental Therapeutics 1994 268 2 662 668 2-s2.0-0028220088 (Pubitemid 24085861)
82. Torres-Alanís O., Garza-Ocañas L., Bernal M. A., Piñeyro-López A., Urinary excretion of trace elements in humans after sodium 2,3-dimercaptopropane-1-sulfonate challenge test. Journal of Toxicology-Clinical Toxicology 2000 38 7 697 700 2-s2.0-0034518887 10.1081/CLT-100102382 (Pubitemid 32047296)
83. Andersen O., Nielsen J. B., Oral cadmium chloride intoxication in mice: effects of penicillamine, dimercaptosuccinic acid and related compounds. Pharmacology & Toxicology 1988 63 386 389 10.1111/j.1600-0773.1988.tb00973.x (Pubitemid 19084059)
84. Centers for Disease Control and Prevention (CDC), Deaths associated with hypocalcemia from chelation therapy-Texas, Pennsylvania, and Oregon, 2003-2005. Morbidity & Mortality Weekly Report 2006 55 204 207
85. Risher J. F., Amler S. N., Mercury exposure: evaluation and intervention. The inappropriate use of chelating agents in the diagnosis and treatment of putative mercury poisoning. NeuroToxicology 2005 26 4 691 699 2-s2.0-23844550637 10.1016/j.neuro.2005.05.004 (Pubitemid 41175902)
86. Flora S. J. S., Pachauri V., Chelation in metal intoxication. International Journal of Environmental Research and Public Health 2010 7 2745 2788 10.3390/ijerph7072745
87. Aposhian M. M., Maiorino R. M., Xu Z., Aposhian H. V., Sodium 2,3-dimercapto-1-propanesulfonate (DMPS) treatment does not redistribute lead or mercury to the brain of rats. Toxicology 1996 109 1 49 55 2-s2.0-0029966404 10.1016/0300-483X(96)03308-2 (Pubitemid 26134789)
88. American Academy of Pediatrics Committee on Environmental Health, Lead exposure in children: prevention, detection, and management. Pediatrics 2005 116 1036 1046 10.1542/peds.2005-1947 (Pubitemid 44542840)
89. Rogan W. J., Dietrich K. N., Ware J. H., Dockery D. W., Salganik M., Radcliffe J., Jones R. L., Ragan N. B., Chisolm J. J., Rhoads G. G., The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. New England Journal of Medicine 2001 344 19 1421 1426 2-s2.0-0035837556 10.1056/NEJM200105103441902 (Pubitemid 32402098)
90. Shannon M., Woolf A., Binns H., Chelation therapy in children exposed to lead. The New England Journal of Medicine 2001 345 1212 1213 10.1056/NEJM200110183451615
91. National Institute of Mental Health-US National Institutes of Health, Mercury Chelation to Treat Autism 2009. http://www.clinicaltrials.gov/ct/show/ NCT00376194?order=40
92. Stangle D. E., Smith D. R., Beaudin S. A., Strawderman M. S., Levitsky D. A., Strupp B. J., Succimer chelation improves learning, attention, and arousal regulation in lead-exposed rats but produces lasting cognitive impairment in the absence of lead exposure. Environmental Health Perspectives 2007 115 2 201 209 2-s2.0-33847077626 10.1289/ehp.9263
93. United States Food and Drug Agency, CHEMET(R) label. NDA 19-998/S-013. 2007, http://www.accessdata.fda.gov/drugsatfda-docs/label/2007/019998s013lbl.pdf
94. Tupe R. P., Chiplonkar S. A., Zinc supplementation improved cognitive performance and taste acuity in Indian adolescent girls. Journal of the American College of Nutrition 2009 28 4 388 396 2-s2.0-77951551375
95. Bhatnagar S., Taneja S., Zinc and cognitive development. British Journal of Nutrition 2001 85 S139 S145 10.1079/BJN2000306 (Pubitemid 32586482)
96. Adams J. B., Baral M., Geis E., The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels. Journal of Toxicology 2009 2009 532640 10.1155/2009/532640
97. Genuis S. J., Toxicant exposure and mental health-individual, social, and public health considerations. Journal of Forensic Sciences 2009 54 474 477 10.1111/j.1556-4029.2008.00973.x
98. Hoet P., Buchet J. P., Decerf L., Lavalleye B., Haufroid V., Lison D., Clinical evaluation of a lead mobilization test using the chelating agent dimercaptosuccinic acid. Clinical Chemistry 2006 52 1 88 96 2-s2.0-29744440880 10.1373/clinchem.2005.051128 (Pubitemid 43032471)
99. Hoffman H. E., Buka I., Phillips S., Medical laboratory investigation of children's environmental health. Pediatric Clinics of North America 2007 54 2 399 415 10.1016/j.pcl.2007.01.006 (Pubitemid 46591918)
100. Brodkin E., Copes R., Mattman A., Kennedy J., Kling R., Yassi A., Lead and mercury exposures: interpretation and action. Canadian Medical Association Journal 2007 176 1 59 63 2-s2.0-33846462077 10.1503/cmaj.060790 (Pubitemid 46144746)
101. Hansen G., Victor R., Engeldinger E., Schweitzer C., Evaluation of the mercury exposure of dental amalgam patients by the Mercury Triple Test. Occupational and Environmental Medicine 2004 61 6 535 540 2-s2.0-2642535260 10.1136/oem.2003.009555 (Pubitemid 38725625)
102. Bradberry S., Sheehan T., Vale A., Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning. The Quarterly Journal of Medicine 2009 102 10 721 732 2-s2.0-70349682356 10.1093/qjmed/hcp114
103. Bradberry S. M., Sheehan T. M. T., Barraclough C. R., Vale J. A., DMPS can reverse the features of severe mercury vapor-induced neurological damage and mercury vapor poisoning. Clinical Toxicology 2009 47 9 894 898 2-s2.0-70350441414 10.3109/15563650903333812
104. Böse-O'Reilly S., Drasch G., Beinhoff C., Maydl S., Vosko M. R., Roider G., Dzaja D., The Mt. Diwata study on the Philippines 2000-treatment of mercury intoxicated inhabitants of a gold mining area with DMPS (2,3-dimercapto-1-propane-sulfonic acid, Dimaval). Science of the Total Environment 2003 307 1-3 71 82 2-s2.0-0242584439 10.1016/S0048-9697(02)00547-8 (Pubitemid 36452340)
105. Adams J. B., Baral M., Geis E., Mitchell J., Ingram J., Hensley A., Zappia I., Newmark S., Gehn E., Rubin R. A., Mitchell K., Bradstreet J., El-Dahr J., Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B-behavioral results. BMC Clinical Pharmacology 2009 9 article 17 2-s2.0-70450280618 10.1186/1472-6904-9-17
106. Lin J. L., Lin-Tan D. T., Hsu K. H., Yu C. C., Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. New England Journal of Medicine 2003 348 4 277 286 2-s2.0-0037461599 10.1056/NEJMoa021672 (Pubitemid 36119982)
107. Lin J. L., Lin-Tan D. T., Yu C. C., Li Y. J., Huang Y. Y., Li K. L., Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes. Kidney International 2006 69 11 2049 2056 2-s2.0-33745229969 10.1038/sj.ki.5001505 (Pubitemid 43924270)
108. Chappell L., Applications of EDTA chelation therapy. Alternative Medicine Review 1997 2 426 432 (Pubitemid 127735683)
109. Seely D. M. R., Wu P., Mills E. J., EDTA chelation therapy for cardiovascular disease: a systematic review. BMC Cardiovascular Disorders 2005 5, article 32 2-s2.0-27844594297 10.1186/1471-2261-5-32 (Pubitemid 41645023)
110. US National Institutes of Health. Department of Health and Human Services. National Institute of Allergy and Infectios Diseases, Trial to Assess Chelation Therapy (TACT). 2011, http://clinicaltrials.gov/ct2/show/NCT00044213
111. Lamas G. A., Goertz C., Boineau R., Design and methodology of the trial to assess chelation therapy (TACT). American Heart Journal 2012 163 1 7 12 10.1016/j.ahj.2011.10.002
112. Atwood K. C., Woockner E., Baratz R. S., Sampson W. I., Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned. The Medscape Journal of Medicine 2008 10 5, article 115 2-s2.0-44349086029
113. Zhao M., Wang Y., Huo C., Lead detoxification activity and ADMET hepatotoxicity of N-(α -l-arabino-furanos-1-yl)-l-cysteine. Chemical Research in Toxicology 2010 23 1282 1285 10.1021/tx100155r
114. Chen W. H., Wang M., Yu S. S., Su L., Zhu D. M., She J. Q., Cao X. J., Ruan D. Y., Clioquinol and vitamin B12 (cobalamin) synergistically rescue the lead-induced impairments of synaptic plasticity in hippocampal dentate gyrus area of the anesthetized rats in vivo. Neuroscience 2007 147 3 853 864 2-s2.0-34250793837 10.1016/j.neuroscience.2007.04.042 (Pubitemid 46990653)
115. Crinnion W., EDTA redistribution of lead and cadmium into the soft tissues in a human with a high lead burden-should DMSA always be used to follow EDTA in such cases? Alternative Medicine Review 2011 16 109 112
116. Chisolm J. J., BAL, EDTA, DMSA and DMPS in the treatment of lead poisoning in children. Journal of Toxicology-Clinical Toxicology 1992 30 4 493 504 2-s2.0-0026439970
117. Tandon S. K., Singh S., Jain V. K., Efficacy of combined chelation in lead intoxication. Chemical Research in Toxicology 1994 7 585 589 10.1021/tx00041a001 (Pubitemid 24302152)
118. Flora S. J. S., Pande M., Mehta A., Beneficial effect of combined administration of some naturally occurring antioxidants (vitamins) and thiol chelators in the treatment of chronic lead intoxication. Chemico-Biological Interactions 2003 145 3 267 280 2-s2.0-0038327890 10.1016/S0009-2797(03)00025-5 (Pubitemid 36549111)
119. Flora S. J., Kannan G. M., Pant B. P., Jaiswal D. K., Combined administration of oxalic acid, succimer and its analogue for the reversal of gallium arsenide-induced oxidative stress in rats. Archives of Toxicology 2002 76 5-6 269 276 2-s2.0-0036016863 10.1007/s00204-002-0347-5 (Pubitemid 34639522)
120. Flora S. J., Pande M., Kannan G. M., Mehta A., Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats. Cellular and Molecular Biology (Noisy-le-Grand, France) 2004 50 OL543 OL551 2-s2.0-5044244052
121. Lithner D., Larsson Å., Dave G., Environmental and health hazard ranking and assessment of plastic polymers based on chemical composition. Science of the Total Environment 2011 409 18 3309 3324 2-s2.0-79959733970 10.1016/j.scitotenv.2011.04.038
122. Marshall L., Taking An Exposure History. 2004, http://www.ocfp.on.ca/ docs/public-policy-documents/taking-an-exposure-history.pdf